I apologize for any confusion. The site is independently owned and operated, and I am in the process of having some technology tweaked, since it languished for several months.

I am also experimenting with Google Ad Sense, which places various ads here. Some of this may be temporary, but I am still in the earliest stages of coordinating necessary tech changes and advertising possibilities. This is a process.

Nonetheless, you raise an interesting point. At this moment, I can only say that I will attempt to monitor what transpires. That said, the site, hopefully, does more than focus on industry conflicts, although that’s clearly an element of the coverage here. There is, however, an attempt to provide a wider mix of topics.

And while I don’t wish to debate the advantages or disadvantages of any one drug or class of drugs, I never stated that I was against or for ADHD drugs. I have heard both points of view over the years from both sides and simply wish to present a forum where news is conveyed and, for those who want to do so, can be discussed.

I hope this helps,
ed

Though disciplined harshly for reporting unsafe conditions I remember reading a study about zyprexa in the late 90’s. It revealed hyperglycemia in patients taking the drug in patients with risk factors of family history of diabetes, obesity and of African decent.

That very same day an African American with a family history of diabetes and obesity was to be discharged. I took it upon myself to get a blood sugar, it was over 200. I reported the results knowing another nurse was suspended providing minor care without an explicit order.

I came back after lunch and found the patient had been discharged. I made a stink to no avail. Previously I had reported 1 RN for 27 patients was unsafe and received a 5-day suspension which led to 2 wrongful terminations and reinstatements through Civil Service.

Patients had committed suicide on several other units and I was outraged, but kept my cool and started a letter writing campaign.

Finally, I was injured on the job and fired a third time.

Even if the meds performed as advertised 1 RN for 27 patients or even 20 patients is not enough to catch all side effects and other problems, monitor patient safety and have meaningful interactions with each patient.

Great reporting. Keep it up, I think your getting their attention.

It was some of the AZ internal memos included in the WSJ last year that made reference to their success burying or spinning studies that associated Seroquel with weight gain/diabetes (and their fear J&J would blow call them on it, having done the same thing with Risperdal).

Crazy, man, crazy.